Untethered Microrobots for Active Drug Delivery: From Rational Design to Clinical Settings
Authors:
- 12 November 2021
- journal article
- review article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (3) , 2102253
Abstract
Recent advances of untethered microrobots, which navigate the complex regions in vivo for therapeutics, have presented promising multiple applications on future healthcare. Microrobots used for active drug delivery system (DDS) have been demonstrated for advanced targeting distribution, improved delivery efficiency, and reduced systemic side effects. In this review, the therapeutic benefits of active DDS are presented compared to the traditional passive DDS, which illustrate the historical reasons for choosing active DDS. An integrated 5D radar chart analysis model containing the core capabilities of the active DDS is innovatively proposed. It would be a practical tool for measurement and mapping of the field of active delivery, followed by the evolutions and bottlenecks of each technical module. The comprehensive consideration of microrobots before clinical application is also discussed from the aspects of robot ethics, dosage, quality control and stability control in actual production. Gastrointestinal and blood administration, as two major clinical scenes of drug delivery, are discussed in detail as examples of the potential bedside applications of active DDS. Finally, combined with the reported analysis model, the current status and future outlook from the translation prospect to the clinical scenes of microrobots are provided.Keywords
Funding Information
- Tsinghua University (2019GQG1016)
This publication has 251 references indexed in Scilit:
- Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriersAdvanced Drug Delivery Reviews, 2012
- Bacterial Isolation by Lectin-Modified MicroenginesNano Letters, 2011
- Challenges and opportunities for structural DNA nanotechnologyNature Nanotechnology, 2011
- Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological BarriersAdvanced Materials, 2011
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences, 2011
- MicroRNA-143 Regulates Human Osteosarcoma Metastasis by Regulating Matrix Metalloprotease-13 ExpressionMolecular Therapy, 2011
- Flow rate and fibrin fiber alignmentJournal of Thrombosis and Haemostasis, 2010
- Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) WarheadsJournal of the American Chemical Society, 2009
- Highly Efficient Drug Delivery with Gold Nanoparticle Vectors for in Vivo Photodynamic Therapy of CancerJournal of the American Chemical Society, 2008
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis modelGene Therapy, 2008